Brendan Hannah - Oct 24, 2023 Form 4 Insider Report for Quince Therapeutics, Inc. (QNCX)

Role
Chief Business Officer and COO
Signature
/s/ Brendan Hannah
Stock symbol
QNCX
Transactions as of
Oct 24, 2023
Transactions value $
$0
Form type
4
Date filed
10/26/2023, 05:54 PM
Previous filing
Aug 9, 2023
Next filing
Feb 2, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QNCX Employee Stock Option (right to buy) Award $0 +75K $0.00 75K Oct 24, 2023 Common Stock 75K $0.99 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the total number of shares subject to the option shall vest and become exercisable on each monthly anniversary of the vesting commencement date of October 23, 2023.